BE
Bonness Enterprises Portfolio holdings
AUM
$305M
1-Year Est. Return
7.94%
1 Year Est. Return
+7.94%
AUM
$305M
AUM Growth
-$548K
(-0.18%)
Holding
38
Top Buys
No buys this quarter
Sector Composition
| 1 | Financials | 44.67% |
| 2 | Technology | 23.88% |
| 3 | Healthcare | 22.46% |
| 4 | Consumer Staples | 2.92% |
| 5 | Industrials | 2.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Progressive
PGR
$132B
| $127M | 41.51% |
512,457
-5,000
|
|
||
2
Stryker
SYK
$135B
| $24.2M | 7.94% |
65,489
|
|
||
3
Microsoft
MSFT
$3.6T
| $21M | 6.9% |
40,600
|
|
||
4
Apple
AAPL
$4.02T
| $13.9M | 4.55% |
54,440
|
|
||
5
AbbVie
ABBV
$394B
| $8.54M | 2.8% |
36,900
|
|
||
6
IBM
IBM
$281B
| $8.34M | 2.74% |
29,564
|
|
||
7
Johnson & Johnson
JNJ
$502B
| $7.16M | 2.35% |
38,638
|
|
||
8
Corning
GLW
$74.5B
| $7.08M | 2.32% |
86,300
|
|
||
9
Cisco
CSCO
$304B
| $6.58M | 2.16% |
96,100
|
|
||
10
Merck
MRK
$250B
| $5.83M | 1.91% |
69,500
|
|
||
11
Emerson Electric
EMR
$74B
| $5.64M | 1.85% |
43,000
|
|
||
12
Applied Materials
AMAT
$201B
| $5.49M | 1.8% |
26,836
|
|
||
13
Thermo Fisher Scientific
TMO
$211B
| $5.3M | 1.74% |
10,935
|
|
||
14
Marsh & McLennan
MMC
$91B
| $5.1M | 1.67% |
25,300
|
|
||
15
Unilever
UL
$142B
| $4.51M | 1.48% |
76,040
|
|
||
16
Abbott
ABT
$218B
| $4.38M | 1.44% |
32,700
|
|
||
17
Pfizer
PFE
$142B
| $4.12M | 1.35% |
161,508
|
|
||
18
Nucor
NUE
$36.1B
| $3.69M | 1.21% |
27,235
|
|
||
19
Intel
INTC
$173B
| $3.28M | 1.08% |
97,850
|
|
||
20
Oracle
ORCL
$517B
| $2.72M | 0.89% |
9,660
|
|
||
21
Procter & Gamble
PG
$340B
| $2.52M | 0.83% |
16,400
|
|
||
22
AT&T
T
$172B
| $2.52M | 0.83% |
89,200
|
|
||
23
Bristol-Myers Squibb
BMY
$109B
| $2.45M | 0.8% |
54,300
|
|
||
24
Philips
PHG
$25.2B
| $2.37M | 0.78% |
86,961
|
|
||
25
Agilent Technologies
A
$38.8B
| $2.3M | 0.75% |
17,900
|
|